<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00891514</url>
  </required_header>
  <id_info>
    <org_study_id>AG0118</org_study_id>
    <secondary_id>R01AG030075</secondary_id>
    <nct_id>NCT00891514</nct_id>
  </id_info>
  <brief_title>Trial of Aerobic Exercise Training in Stroke Survivors</brief_title>
  <official_title>Aging, Inflammation and Exercise in Chronic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baltimore VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Baltimore VA Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effects of treadmill training on inflammation in&#xD;
      the skeletal muscle and adipose tissue, insulin action in the skeletal muscle, and whole body&#xD;
      glucose metabolism in stroke survivors. The fundamental hypothesis of this study is that key&#xD;
      inflammatory markers in adipose tissue and skeletal muscle are abnormal, skeletal muscle&#xD;
      insulin signaling is impaired, and systemic insulin sensitivity is reduced in hemiparetic&#xD;
      stroke patients and that these factors are modifiable and improved by exercise training in&#xD;
      stroke patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many stroke survivors are sedentary and are at risk for the development of diabetes. We will&#xD;
      study the interactions of adipose tissue and the paretic and non-paretic muscle inflammation,&#xD;
      insulin signaling and action in hemiparetic stroke patients and the ability to employ&#xD;
      exercise training to reverse these abnormalities in this ethnically diverse population.&#xD;
      Participants aged 40-75 years with chronic stroke will be randomized to treadmill training&#xD;
      versus stretch control group using a one-two-one blocked randomization on race (black vs.&#xD;
      white), sex (male vs. female), and glucose tolerance status (normal vs. impaired and type 2&#xD;
      diabetes).&#xD;
&#xD;
      Stroke occurs in over 780,000 persons each year in the U.S., the vast majority reported in&#xD;
      persons older than 55 years of age. Following stroke, patients remain at continued high risk&#xD;
      for recurrent stroke. Inflammatory processes lead to cardiovascular events/stroke and&#xD;
      contribute to disease risk progression by impacting insulin resistance and the development of&#xD;
      type 2 diabetes. Interventions that reduce inflammation and improve insulin sensitivity have&#xD;
      important clinical implications, especially in the stroke population.&#xD;
&#xD;
      Task-oriented treadmill training is utilized to improve cardiovascular fitness and functional&#xD;
      mobility in hemiparetic stroke patients. Additionally, preliminary data indicates that&#xD;
      progressive treadmill training in this population improves glucose tolerance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2009</start_date>
  <completion_date type="Actual">July 31, 2018</completion_date>
  <primary_completion_date type="Actual">July 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VO2peak</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>maximal oxygen consumption during a treadmill test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Whole body insulin sensitivity</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>glucose utilization during a glucose clamp</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cytokines</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>circulating TNF alpha levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>whole body percent fat</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle mass</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>whole body lean mass</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Stroke</condition>
  <condition>Insulin Resistance</condition>
  <condition>Sedentary Lifestyle</condition>
  <arm_group>
    <arm_group_label>Aerobic Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treadmill training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stretch Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stretching exercises</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Aerobic Exercise</intervention_name>
    <description>Treadmill training- begins at 15 minutes total duration at 40-50% maximal heart rate reserve 3 times per week, increasing to 60-70% maximal heart rate reserve for 45-60 minutes for 6 months</description>
    <arm_group_label>Aerobic Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stretching</intervention_name>
    <description>Stretching, balance exercises, and components of conventional physical therapy-- begins at 15 minutes and progresses to 45 minutes for 6 months</description>
    <arm_group_label>Stretch Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ischemic or hemorrhagic stroke greater than or equal to 6 months prior with stable&#xD;
             residual hemiparetic gait deficits&#xD;
&#xD;
          -  Already completed all conventional inpatient and outpatient physical therapy&#xD;
&#xD;
          -  Adequate language and neurocognitive function to safely participate in exercise&#xD;
             testing and training&#xD;
&#xD;
          -  Men or women ages 40-75 years&#xD;
&#xD;
          -  Body mass index between 20 to 50 kg/m2&#xD;
&#xD;
          -  Non-smoker, or history of no smoking for more than 5 years&#xD;
&#xD;
          -  Under the care of a primary care medical provider&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Already performing aerobic exercise 3 times a week&#xD;
&#xD;
          -  Increased alcohol consumption defined as greater than 2 oz. liquor or 8 oz. of wine or&#xD;
             24 oz. of beer per day&#xD;
&#xD;
          -  Cardiac history of:&#xD;
&#xD;
               1. unstable angina&#xD;
&#xD;
               2. recent (less than 3 months prior to study entry) myocardial infarction,&#xD;
                  congestive heart failure&#xD;
&#xD;
               3. hemodynamically significant valvular dysfunction&#xD;
&#xD;
          -  Medical History:&#xD;
&#xD;
               1. recent hospitalization (less than 3 months prior to study entry) for severe&#xD;
                  medical disease&#xD;
&#xD;
               2. peripheral arterial disease with vascular claudication&#xD;
&#xD;
               3. orthopedic or chronic pain condition restricting exercise&#xD;
&#xD;
               4. pulmonary or renal failure&#xD;
&#xD;
               5. active cancer&#xD;
&#xD;
               6. untreated poorly controlled hypertension measured on at least 2 occasions&#xD;
                  (greater than 160/100)&#xD;
&#xD;
               7. type I diabetes mellitus, insulin therapy, untreated and/or poorly controlled&#xD;
                  diabetes with fasting blood glucose of greater than 160&#xD;
&#xD;
               8. smoking within the last 5 years&#xD;
&#xD;
               9. allergy to lidocaine&#xD;
&#xD;
              10. medications: heparin, warfarin, lovenox, beta-blockers, oral steroids&#xD;
&#xD;
          -  Neurological history of:&#xD;
&#xD;
               1. dementia with Mini-Mental Status Score less than 23 (less than 17 if education&#xD;
                  level at or below 8th grade), and diagnostic confirmation by neurologist or&#xD;
                  psychiatrist&#xD;
&#xD;
               2. severe receptive or global aphasia which confounds testing and training,&#xD;
                  operationally defined as unable to follow 2 point commands&#xD;
&#xD;
               3. hemiparetic gait from a prior stroke preceding the index stroke defining&#xD;
                  eligibility (more than one stroke)&#xD;
&#xD;
               4. neurologic disorder restricting exercise, such as Parkinsons Syndrome or myopathy&#xD;
&#xD;
               5. untreated major depression&#xD;
&#xD;
          -  Adipose tissue and muscle biopsy exclusion criteria:&#xD;
&#xD;
               1. anti-coagulation therapy with heparin, warfarin, or lovenox (anti-platelet&#xD;
                  therapy is permitted)&#xD;
&#xD;
               2. bleeding disorder&#xD;
&#xD;
               3. allergy to lidocaine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alice S. Ryan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland, VA Research Service</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charlene Hafer-Macko, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland, VA Research Service, Department of Neurology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Maryland, VAMC</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>20705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ryan AS, Dobrovolny CL, Smith GV, Silver KH, Macko RF. Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Arch Phys Med Rehabil. 2002 Dec;83(12):1703-7.</citation>
    <PMID>12474173</PMID>
  </reference>
  <reference>
    <citation>Hafer-Macko CE, Yu S, Ryan AS, Ivey FM, Macko RF. Elevated tumor necrosis factor-alpha in skeletal muscle after stroke. Stroke. 2005 Sep;36(9):2021-3. Epub 2005 Aug 18.</citation>
    <PMID>16109906</PMID>
  </reference>
  <reference>
    <citation>Ivey FM, Ryan AS, Hafer-Macko CE, Goldberg AP, Macko RF. Treadmill aerobic training improves glucose tolerance and indices of insulin sensitivity in disabled stroke survivors: a preliminary report. Stroke. 2007 Oct;38(10):2752-8. Epub 2007 Aug 16.</citation>
    <PMID>17702957</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>April 30, 2009</study_first_submitted>
  <study_first_submitted_qc>April 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2009</study_first_posted>
  <last_update_submitted>October 10, 2018</last_update_submitted>
  <last_update_submitted_qc>October 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baltimore VA Medical Center</investigator_affiliation>
    <investigator_full_name>Alice S. Ryan, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Exercise</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Insulin Sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

